Asia-Pacific Enteral Feeding Formula Market, By Product (Standard Formulas, Diabetic Formula, Renal Formula, Hepatic Formula, Pulmonary Formula, Peptide-based Formula, Other Disease Specific Formula, and Disease-Specific Formulas), Application (Oncology, Neurology, Critical Care, Diabetes, Gastroenterology, and Others), Type of Tube Feeding (Gastric Tube Feeding, Nasogastric Tube Feeding, Gastrostomy Tube Feeding, and Duodenal or Jejunal Tube Feeding), Stage (Adult and Pediatric), End User (Hospitals, Nursing Homes, Assisted Living Facilities, Home Care Agencies, and Hospices and Long Term Care Facilities) – Industry Trends and Forecast to 2030.
Asia-Pacific Enteral Feeding Formula Market Analysis and Size
According to the World Health Organization, nearly 70% of cancer fatalities occur in low- and middle-income countries. As a result of rising chronic diseases and disorders, a rapidly aging population, a rising rate of premature birth, rising healthcare expenses, and increased demand for home care, the enteral feeding formula industry is expanding.
Data Bridge Market Research analyses that the enteral feeding formula market, which was USD 0.58 billion in 2022, is expected to reach USD 1.02 billion by 2030, at a CAGR of 7.3% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Asia-Pacific Enteral Feeding Formula Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product (Standard Formulas, Diabetic Formula, Renal Formula, Hepatic Formula, Pulmonary Formula, Peptide-based Formula, Other Disease Specific Formula, and Disease-Specific Formulas), Application (Oncology, Neurology, Critical Care, Diabetes, Gastroenterology, and Others) Type of Tube Feeding (Gastric Tube Feeding, Nasogastric Tube Feeding, Gastrostomy Tube Feeding, and Duodenal or Jejunal Tube Feeding), Stage (Adult and Pediatric), End User (Hospitals, Nursing Homes, Assisted Living Facilities, Home Care Agencies, and Hospices and Long Term Care Facilities)
|
|
Countries Covered
|
China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC)
|
|
Market Players Covered
|
Nutricia (Netherlands), Hormel Foods Corporation (U.S), Medline Industries, Inc. (U.S), Mead Johnson & Company, LLC. (U.S), Nestlé Health Science (Switzerland), Abbott (U.S), Meiji Holdings Co., Ltd. (Japan), Fresenius Kabi AG (Germany), B. Braun SE (Germany), Trovita Health Science (U.S), Victus Inc. (U.S), Avanos Medical Inc. (U.S), Cardinal Health (U.S), Moog Inc (U.S), Conmed Corporation (U.S), Cook Medical (India)
|
|
Market Opportunities
|
|
Market Definition
Enteral tube feeding is introducing nutrients into the intestines or stomach through tubes for those unable to meet their nutritional demands or absorb nutrients orally. Tubes such as nasojejunal tubes, gastrostomy tubes, nasogastric tubes, and jejunostomy tubes are offered for enteral feed formula. The many methods for delivering the needed nutrients are cost-effective, nutritious, and a viable alternative to intrusive surgery.
Enteral Feeding Formula Market Dynamics
Drivers
- Rise in the geriatric population and chronic diseases in them
The Asia-Pacific geriatric population is steadily growing, resulting in an increase in chronic diseases in the region. The EU-27's growing elderly population (those aged 85 and up) has several implications. The cost of providing good health and long-term care is one of the main sources of concern for the concerned authority, as extremely elderly people require proportionally more social services. Furthermore, because neurological illnesses such as multiple sclerosis, stroke, and dementia impair swallowing, the elderly population is the market's primary target consumer.
- Expansion in product portfolio
The development of product portfolios by major market players is attributed to driving growth in the Asia-Pacific market for enteral feeding formulas. Leading pharmaceutical and nutraceutical companies invest in research and development (R&D), resulting in market-leading product discoveries. The introduction of ready-to-drink (RTD) products, ready-to-use nutritional supplements, and improved tube quality are all helping to propel the market forward.
Opportunities
- New product launches in the enteral feeding market
In recent years, the Asia-Pacific enteral feeding market has seen new product releases. These unique product developments are a component of the market's enormous prospective opportunities. Furthermore, technological advancements and product innovations are two major factors driving the enteral feeding formula market forward. The broad product portfolios and robust product developments of key companies assist the market's expansion. Some product categories that have gained traction in recent years include ready-to-drink (RTD), ready-to-use nutritional supplements, tube feed, and tube feed for specific specialized uses.
Restraints/Challenges
- Complications associated with enteral feeding
According to the National Center for Biotechnology Information, gastrostomy and jejunostomy feeding tubes are commonly implanted and used for long-term home enteral nutrition support. Although the insertion of these tubes is usually associated with minor morbidity, long-term use can result in various problems and diseases that can reduce the quality of life and have serious financial consequences. All these factors contribute to the region's slow expansion of the enteral feeding formula market.
This enteral feeding formula market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the enteral feeding formula market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Enteral Feeding Formula Market
According to a study published in the Society of Critical Care Medicine and the American Society for Parenteral and Enteral Nutrition, starting early enteral nutrition (EN) within 24-36 hours of ICU admission or within 12 hours of intubation and placement on automatic aeration is recommended in the treatment of COVID-19 patients. The COVID-19 outbreak is expected to impact the enteral feeding formula market because good supportive care remains the cornerstone in dealing with critically ill patients with COVID-19 infection, and nutritional management of ICU-admitted COVID-19 patients is an integral component of supportive measures.
Recent Development
- In October 2020, Nestle Health Science launched China's first ready-to-drink protein-based total nutrition Foods for Special Medical Purposes (FSMPs) for malnourished people.
- In June 2020, Otuska Pharmaceuitical Factory Inc. launched Enoras Liquid, an enteral polymeric enteric nutrition.
Asia-Pacific Enteral Feeding Formula Market Scope
The enteral feeding formula market is segmented on the basis of product, stage, type of tube feeding, indication and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Standard formula
- Disease-specific formula
- Diabetic Formula
- Renal Formula
- Hepatic Formula
- Pulmonary Formula
- Peptide-based Formula
- Other Disease Specific Formula
Stage
- Adult
- Pediatric
Indication
- Alzheimer's
- Nutrition Deficiency
- Cancer Care
- Diabetes
- Chronic Kidney Diseases
- Orphan Diseases
- Dysphagia
- Pain Management
- Malabsorption/G.I. Disorder/Diarrhea
- Others
Type of Tube Feeding
- Gastric Tube Feeding
- Nasogastric Tube Feeding
- Gastrostomy Tube Feeding
- Duodenal or Jejunal Tube Feeding
End-user
- Hospitals
- Cardiology
- Neurology
- Critical Care (ICU)
- Oncology
- Others
- Home Care
- Nursing Homes
- Assisted Living Facilities
- Home Care Agencies
- Hospices
Enteral Feeding Formula Market Regional Analysis/Insights
The enteral feeding formula market is analysed and market size insights and trends are provided by country, product, stage, type of tube feeding, indication and end-user as referenced above.
The countries covered in the enteral feeding formula market report are China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC)
The Asia-Pacific region is expected to grow from 2023 to 2030 due to growing awareness regarding early diagnosis. China is dominating the Asia-Pacific market because of the region's increasing incidence of preterm births and growing healthcare expenditure by the government.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of Asia-Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Enteral Feeding Formula Market Share Analysis
The enteral feeding formula market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Asia-Pacific presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to enteral feeding formula market.
Some of the major players operating in the enteral feeding formula market are:
- Nutricia (Netherlands)
- Hormel Foods Corporation (U.S)
- Medline Industries, Inc. (U.S)
- Mead Johnson & Company, LLC. (U.S)
- Nestlé Health Science (Switzerland)
- Abbott (U.S)
- Meiji Holdings Co., Ltd. (Japan)
- Fresenius Kabi AG (Germany)
- B. Braun SE (Germany)
- Trovita Health Science (U.S)
- Victus Inc. (U.S)
- Avanos Medical Inc. (U.S)
- Cardinal Health (U.S)
- Moog Inc (U.S)
- Conmed Corporation (U.S)
- Cook Medical (India)
SKU-